Back to 
BlackRock, Inc.
BlackRock, Inc.
CPRX7 quarters
Position history for BlackRock, Inc.'s holdings in CATALYST PHARMACEUTICALS INC
BlackRock, Inc. holds 19.2M shares of CPRX (CATALYST PHARMACEUTICALS INC), worth $602.2M as of 2026-Q2. The position was increased (+2.0% shares). CPRX represents 0.0% of BlackRock, Inc.'s portfolio.
Current Value
$602.2M
Current Shares
19.2M
Total Value Change
+$196.8M
Total Shares Change
-266,344
Quarter-by-Quarter History
Other major holders of CPRX: BlackRock Finance, Inc., STATE STREET CORP, VANGUARD GROUP INC